Supriya Lifescience Aims To Double Revenue To Rs 1,000 Crore By FY27 — Know Your Company
9 months ago•Bloomberg Quint
Supriya Lifescience Q3 Review - Strong Growth Across Board On Favorable Geographical, Product Mix: DRChoksey
9 months ago•Bloomberg Quint
Supriya Lifescience shares rise post tie-up with US-based Plasma Nutrition
1 year ago•The Hindu Businessline
Supriya Lifescience ties up with US-based Plasma Nutrition, stock surges 7%
1 year ago•Business Today
Buy Supriya Lifescience; target of Rs 278: KR Choksey
1 year ago•Moneycontrol
Supriya Lifescience - Muted Performance On Account Of Multiple Macro Headwinds: KRChoksey
1 year ago•Bloomberg Quint
EKI Energy Services Ltd leads gainers in ‘A’ group
1 year ago•Business Standard